These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1594743)

  • 1. Detecting colorectal cancer with a large scale fecal occult blood testing program.
    Gregorio DI; Lolachi P; Hansen H
    Public Health Rep; 1992; 107(3):331-5. PubMed ID: 1594743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients diagnosed with colorectal cancer through a television-advertised screening program.
    Slusser SO; Liberski SM; McGarrity TJ
    Am J Gastroenterol; 1996 Aug; 91(8):1563-6. PubMed ID: 8759662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population colorectal cancer screening with fecal occult blood test.
    Rennert G; Rennert HS; Miron E; Peterburg Y
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a repeat television-advertised mass screening program for colorectal cancer using fecal occult blood tests.
    McGarrity TJ; Long PA; Peiffer LP
    Am J Gastroenterol; 1990 Mar; 85(3):266-70. PubMed ID: 2309678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer screening through detection of fecal occult blood in a controlled health zone.
    Tárraga P; García-Olmo D; Celada A; García-Molinero Mf; Divison JA; Casado C
    Rev Esp Enferm Dig; 1999 May; 91(5):335-44. PubMed ID: 10362875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal occult blood testing: comparative evaluation of a two-hole versus a three-hole single slide test.
    Porschen R; Kruis W; Strohmeyer G
    Hepatogastroenterology; 1993 Apr; 40(2):191-3. PubMed ID: 8509054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of immunological fecal occult blood testing for colorectal cancer screening.
    Nakama H; Kamijo N
    Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
    Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
    Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal occult blood testing for colorectal cancer in an ethnically diverse population.
    Glober GA; Hundahl S; Stucke J; Choy M
    West J Med; 1994 Oct; 161(4):377-82. PubMed ID: 7817548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary report about the screening program for colorectal cancer by sequential fecal occult blood in Wuhan area for 4 years].
    Lu ZM; Chen JG; Zhang YX; Wang Q; Xu J; Chen C; Yang R; Xiong F; Liu C; Peng XH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):474-6. PubMed ID: 19742337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital rectal fecal occult blood screening during gynecologic examination.
    Willis FL; Fanning J
    Am J Obstet Gynecol; 2004 May; 190(5):1422-3. PubMed ID: 15167856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a television-advertised public screening program for colorectal cancer.
    McGarrity TJ; Long PA; Peiffer LP; Converse JO; Kreig AF
    Arch Intern Med; 1989 Jan; 149(1):140-4. PubMed ID: 2912403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance.
    Manfredi S; Piette C; Durand G; Plihon G; Mallard G; Bretagne JF
    Endoscopy; 2008 May; 40(5):422-7. PubMed ID: 18231963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.